Questions: Monopoly Market Power and Barriers to Entry

Question 1

A pharmaceutical company earns large profits on a cancer drug that costs $5 to manufacture but sells for $500. A biotech startup wants to produce the same compound. What is the most likely reason they cannot?

• A. Economies of scale — the pharmaceutical company produces cheaply, so the startup can't compete on cost
• B. Network effects — patients are already using the incumbent's drug, so the startup can't attract users
• C. A patent — a legal barrier deliberately granting the innovator temporary exclusivity to recover R&D investment
• D. Control of essential inputs — the pharmaceutical company owns the raw materials

Answer: (C)

The pharmaceutical industry's dominant barrier is patent protection — a legal monopoly deliberately created by governments to incentivize risky, expensive R&D. Without patent protection, competitors would immediately copy new drugs, and no firm would invest billions in clinical trials. The high price-to-cost ratio is a feature, not a bug: it funds future innovation. This distinguishes legal barriers (patents, licenses) from natural barriers (economies of scale) and strategic barriers (exclusive contracts). The source of the barrier determines whether policy intervention is appropriate.

Question 2

Which of the following best characterizes a natural monopoly?

• A. A firm that controls a natural resource essential to its industry
• B. A market where a single firm can serve all demand at lower average cost than two or more firms could
• C. A monopoly that arises without any government involvement
• D. A firm so large that competitors cannot match its brand recognition

Answer: (B)

A natural monopoly arises from the cost structure of an industry: when fixed costs are very large relative to variable costs (water pipes, electricity grids, rail infrastructure), average cost falls continuously over the range of market demand. Splitting the market between two firms would leave each operating at a smaller scale with higher unit costs, making consumers worse off. Option A describes control of inputs, not the cost-structure definition. Option C is appealing but imprecise — natural monopolies typically require regulatory approval or arise in regulated contexts. Option D describes brand loyalty (a soft barrier), not natural monopoly.

Question 3

In competitive markets, economic profit is temporary because it attracts entry. Entry barriers are what allow monopoly profit to persist in the long run.

• T. True
• F. False

Answer: True

This is the core logic: profit is a signal that capital is earning more here than elsewhere. In competitive markets, this signal triggers entry, which increases supply, drives prices down, and erodes profit until normal returns are restored. Entry barriers block this signal from translating into entry. Whether the barrier is a patent, economies of scale, network effects, or control of inputs, its function is the same: preventing the market mechanism from distributing the profit away. Without barriers, even a current monopolist would lose its position to competition.

Question 4

Monopolists generally earn positive economic profit in the long run because they face no competition.

• T. True
• F. False

Answer: False

Monopoly status prevents *competitor* entry but does not guarantee profit. A monopolist faces the market demand curve, and if demand is weak (inelastic at low quantities, or consumers simply don't value the product enough), the profit-maximizing price and quantity may still yield negative economic profit. A monopolist with high fixed costs and low demand can run losses indefinitely — it just can't be displaced by a competitor who notices those losses. Entry barriers protect market position, not profitability.

Question 5

Why does identifying the source of a monopoly's entry barriers matter for policy decisions, rather than simply declaring all monopolies harmful and breaking them up?

Model answer: Different barriers reflect different economic realities. Some barriers, like economies of scale in natural monopolies (water, electricity), reflect genuine efficiencies — splitting the market would raise costs for everyone. Network effects may similarly reflect real value created by scale. Breaking up such monopolies destroys efficiency without improving competition. Other barriers, like predatory pricing, exclusive dealing contracts designed to foreclose rivals, or regulatory capture, are strategic manipulations that generate no social benefit. Policy should preserve efficient barriers while targeting anticompetitive ones. Treating all monopolies the same ignores whether the barrier is creating value or just extracting it.

This connects to the broader principle that monopoly is not inherently bad — it depends on why the monopoly exists and what it does with its market power. The Lerner Index (price-marginal cost markup) measures monopoly power, but policy analysis requires knowing whether that power rests on cost advantages, legal grants, or exclusionary conduct. Only the last category is unambiguously welfare-reducing.